Last reviewed · How we verify
NCT04573595: BPM2
Fresenius Noninvasive Blood Pressure Validation
NA trial testing Blood Pressure Measurement in Blood Pressure in 159 participants. Completed in 4 December 2020.
4 December 2020
Quick facts
| Lead sponsor | Fresenius Medical Care North America |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 159 |
| Start date | 17 September 2020 |
| Primary completion | 4 December 2020 |
| Estimated completion | 4 December 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood Pressure Measurement
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
Sponsor
Fresenius Medical Care North America — full company profile →
Who can join
13 and older, any sex, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study to collect blood pressure measurement values from the blood pressure measurement device on the Fresenius machine as compared to the standard method.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04573595
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood Pressure Measurement
Trials testing the same drug.
- NCT05993481 — The Noninvasive Blood Pressure Measurement Effect on the Hypotension · NA · enrolling by invitation
- NCT04467021 — Cancer and Blood Pressure Management, CARISMA Study · NA · active not recruiting
- NCT04216732 — Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · recruiting
- NCT02811055 — Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Asso · Phase 2 · completed
- NCT03588559 — Clinical Trial of Blood Pressure Monitor in Conformance With the ANSI/AAMI ISO 81060-2 Standard · NA · completed
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other Fresenius Medical Care North America trials
Trials by the same sponsor.
- NCT05339139 — SAfety of Regional Citrate Anticoagulation (SARCA Study) · Phase 3 · recruiting
- NCT04511338 — Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ · NA · completed
- NCT03536663 — Clinical Study to Assess the Performance of the Dialyzer With Endexo™ · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04573595 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fresenius Medical Care North America
- Last refreshed: 2 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04573595.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing